# UNIVERSITY OF MICHIGAN AT ANN ARBOR: CD38 modulation of NAD metabolism driving scleroderma pathogenesis

**Lab Budget Score:** 55/100

| Field | Value |
|---|---|
| Organization | UNIVERSITY OF MICHIGAN AT ANN ARBOR |
| Location | ANN ARBOR, MI |
| Project | CD38 modulation of NAD metabolism driving scleroderma pathogenesis |
| Project number | 5R01AR081788-04 |
| Mechanism | R01 |
| Institute | National Institute of Arthritis and Musculoskeletal and Skin Diseases |
| Award | $635,184 |
| Awarded | 2026-08-27 |
| Project period | 2023-09-01 to 2028-08-31 |
| UEI | GNJ7BBP73WE9 |

## Why this score
- Award of $400K or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11401084). Last refreshed: 2026-11-04T21:37:56.465Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.